Sponsored content: this article was produced by a third-party contributor and does not reflect the views of The Industry Leaders. Editorial & Advertising Policy. Probate disputes in England and Wales aren't just rising; they're setting new records every year, and the numbers all point the same way: this is a structural trend, not a blip. As mentioned by a variety of sources associated with UK inheritance dispute statistics, in 2025, a record 1,217 disputed probate cases were

An interview with Izabella Stueflotten Cybersecurity strategist Izabella Stueflotten In an era where cyber threats are evolving at a breakneck pace and regulatory pressures are at an all-time high, Izabella Stueflotten is a voice of clarity. As the VP of Digital Security Strategy at Elasticito, Izabella has carved out a distinguished career spanning more than two decades, rising to the highest echelons of the male-dominated cybersecurity sector to lead European contracts for

Sponsored content: this article was produced by a third-party contributor and does not reflect the views of The Industry Leaders. Editorial & Advertising Policy. Buying a business usually involves months of preparation. Lawyers review contracts, accountants examine the finances and both parties spend time making sure assets are transferred correctly. Customer databases, intellectual property, equipment, and trading names are all discussed in detail because everyone understand

Sponsored content: this article was produced by a third-party contributor and does not reflect the views of The Industry Leaders. Editorial & Advertising Policy. For decades, alcohol has been a familiar feature of business networking. From after-work drinks and client dinners to industry conferences and corporate celebrations, sharing a drink has often been viewed as a way to break the ice and strengthen professional relationships. However, attitudes towards alcohol are chang

For many businesses, that level of due diligence was enough because relationships were often local, transactions happened face-to-face, and there were fewer opportunities for bad actors to hide behind layers of digital infrastructure.

Sponsored content: this article was produced by a third-party contributor and does not reflect the views of The Industry Leaders. Editorial & Advertising Policy. The global pharmaceutical industry learned an uncomfortable lesson between 2022 and 2025. Drug shortages aren't caused by bad luck. They're caused by structural weaknesses in how and where active pharmaceutical ingredients are made. Adderall shortages that began in late 2022 stretched into 2024, affecting millions of